asa glp 1 The 2023 position on GLP-1 receptor agonists has been overturned by three 2025 consensus statements. Continue the drug. Change the fast. ANZCA/ADS/GESA/NACOS, the Association of Anaesthetists/RCoA, and SPAQI/AACE now converge on Anesthesiologists' Perspectives on GLP-1 Receptor

Patients who switched were more likely to continue treatment and showed higher adherence than those who remained on their initial medication, suggesting adjustments often reflected active management

DOI: 10.3390/nu17101733,

NAD+ is essential for cellular respiration, with roles in glycolysis, the Krebs cycle, and the electron transport chain

Transdermal psoriasis treatment inspired by tumor microenvironment-mediated immunomodulation and advanced by exosomal engineering

In particular, NRF2 strongly activates cystine uptake coupled with glutamate excretion and glutathione synthesis, which increases consumption of intracellular glutamate